Improving Immunotherapy Strategies for Cancers
Attend this webinar to hear how two cancer research teams developed ways for identifying tumor-specific targets that would otherwise be invisible to the human immune system.
New York University's Dr. Mark Yarmarkovich will share how he and his team developed a way to integrate large-scale genomic data sets with experiments that survey the landscape of neuroblastoma peptides presented on human leukocyte antigens.
Roswell Park Cancer Center's Dr. A.J. Robert McGray will discuss how his team has engineered T cells to secrete tumor-specific BiTE-T cells for adoptive T cell therapy in ovarian cancer.
This junior investigator session is tied to the Cancer Moonshot SM Blue Ribbon Panel report’s recommendations to create both an adult immunotherapy network and a pediatric immunotherapy discovery and development network.
Dr. McGray is the assistant professor of oncology and immunotherapy at the Roswell Park Comprehensive Cancer Center in Buffalo, New York.
Dr. Yarmarkovich is a principal investigator and assistant professor at New York University School of Medicine.
Upcoming Events
-
Predicting Patients’ Response to Immunotherapy from Tumor Histopathology and Blood: Computational Science in Immuno-oncologyJuly 08, 2025Data Jamboree: Enhancing Childhood Cancer Data Sharing and UtilitySeptember 29, 2025 - September 30, 2025NCI Office of Data Sharing’s Annual Data Sharing Symposium 2025: How Data Advances the Impact of Cancer ResearchSeptember 30, 2025 - October 01, 2025Childhood Cancer Data Initiative (CCDI) Symposium 2025October 06, 2025 - October 07, 2025